2021
DOI: 10.1186/s10194-021-01339-y
|View full text |Cite
|
Sign up to set email alerts
|

Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire

Abstract: Background The MIDAS is the most used questionnaire to evaluate migraine-related disability, but its utility to assess treatment response remains unclear. Our aim was to estimate the MIDAS’ minimal important change (MIC) value and its responsiveness. Methods A total of 103 patients were enrolled in a non-pharmacological, preference-based clinical trial. MIDAS and global rating of self-perceived change (GRoC) scores were collected at baseline, after… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 13 publications
0
19
0
Order By: Relevance
“…And the Mini-mental Status Examination (MMSE) was evaluated to test cognitive function of subjects [ 21 ] too. In addition, the migraine patients’ disability was quantified using the Migraine Disability Assessment (MIDAS) [ 22 ]. 0–5 indicates mild disability or no disability; 6–10 indicates mild disability; 11–20 indicates moderate disability; ≥ 21 indicates severe disability [ 23 ].…”
Section: Methodsmentioning
confidence: 99%
“…And the Mini-mental Status Examination (MMSE) was evaluated to test cognitive function of subjects [ 21 ] too. In addition, the migraine patients’ disability was quantified using the Migraine Disability Assessment (MIDAS) [ 22 ]. 0–5 indicates mild disability or no disability; 6–10 indicates mild disability; 11–20 indicates moderate disability; ≥ 21 indicates severe disability [ 23 ].…”
Section: Methodsmentioning
confidence: 99%
“…The MCIC for MIDAS after non-pharmacologic treatment has been determined as 4.5 points [ 46 ]. A pediatric version of MIDAS has been developed [ 47 ] and validated for ages 4–18 years. PedMIDAS is like the adult version; however, a major drawback of the scale is that it relies on the child’s recall over the past 3 months.…”
Section: The Use Of Clinical Scales and Proms In Headache Disorders A...mentioning
confidence: 99%
“…The ANOVA showed a significant effect of time at three-month follow-up for both groups (within-group differences p = 0.001) but a between groups difference for MIDAS scores was not observed evaluating the interaction of time and group. A change of 4.5 points or more in four weeks (for three months = 13.5 points) represents a clinically significant change for patients with frequent episodic and chronic migraine (58). Improvement values at follow-up were far above this minimally important change cut-off in both groups with a strong effect size (d = 1.15).…”
Section: Discussionmentioning
confidence: 99%